This is the authors' abstract. We don't add key points for this paper.
, 3451). More extensively, we identified two additional regions of the LDD receptor, regions II and III, suitable for binding to larger AβO species at the SP1 with different molecular weights and conformations, accounting for the stronger binding strength obtained experimentally. We suggest that the two regions are more competitive than region I in causing toxicity by AβO binding. The detailed and systematic characterization for the complexes generated between the LDD receptor and various AβO species, including the protofibril, offers deep insight into the dependence of neurotoxicity on the AβO size and conformation at the molecular level, and provides novel and specific targets for drug design of Alzheimer's disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: